alternatives to glp-1 agonists comparison of glp 1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? alternative to glp 1 GLP-1

Current pharmaceutical design

DUAL GLUCAGON/GLUCAGON-LIKE PEPTIDE-1 RECEPTOR CO-AGONISTS As part of the ongoing effort to use synergistic effects of gastrointestinal hormones in the treatment of diabetes and obesity, the first GIP/GLP-1 receptor co-agonist was reported in 2013

Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer

Thus GLP-1 was shown to regulate a number of diverse functions: reduction in digestive enzyme secretion, slowing of gastric motility, increases in heart rate and blood flow, increased bone remodeling, and suppression of appetite (via hypothalamic and brainstem nuclei)

Long-term safety remains a central question

One particularly notable case report described a 23-year-old female who developed alopecia areata, an autoimmune form of hair loss, just two months after starting semaglutide